# OnCo record medicare-ncd-190-28 (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/medicare-ncd-190-28/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "medicare-ncd-190-28" ;
  schema:name "Medicare NCD 190.28: CA 125 tumour marker test"@en ;
  schema:alternateName "NCD 190.28"@en, "Tumor Antigen by Immunoassay - CA 125"@en, "Medicare CA-125 coverage"@en ;
  schema:description "Medicare pays for the CA 125 blood test to follow ovarian and related cancers after diagnosis, to check for recurrence and response to treatment, but not to diagnose a pelvic mass or to investigate symptoms."@en ;
  schema:url <https://onco.cc/terms/medicare-ncd-190-28/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=130&ncdver=2>, <https://api.coverage.cms.gov/v1/data/ncd?ncdid=130&ncdver=2> ;
  onco:tag "us" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/mesothelioma/> ;
  onco:institutions <https://onco.cc/institutions/cms/> ;
  onco:terms <https://onco.cc/terms/ca-125/> .